Study Stopped
Covid prevented us from performing the study and the funding ran out
VIM DBS Respiratory Modulation: N-of-1 Trial
Respiratory Modulation by VIM Deep Brain Stimulation: N-of-1 Trial of Breath-holding and Peak Expiratory Flow
1 other identifier
observational
N/A
0 countries
N/A
Brief Summary
Research from our group has demonstrated modulation of PEFR in patients with STN and PAG stimulation. However, the effect of VIM (motor thalamus) stimulation remains to be investigated. Our group has also been involved in research that indicates that VIM stimulation may reduce perception of breathlessness. However, methodological factors limit the conclusions that can be drawn from this prior work. N-of-1 trials, organised as a randomised multiphase crossover design, are uniquely well suited for DBS research where stimulation can be switched ON and OFF, and with simple tests that can be done quickly, multiple times. PEFR and breath-holding are simple tests that we will test in this way. Other respiratory tests will be carried out along side, as optional, in a single phase design. We aim to offer this study to a continuous cohort of patients scheduled to undergo VIM (ET/DT) DBS at our institution. We will establish a pre-operative baseline of respiratory function, and then perform the n-of-1 trial post-operatively, soon after the patient returns to hospital to receive their DBS programming.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Sep 2021
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 27, 2021
CompletedStudy Start
First participant enrolled
September 9, 2021
CompletedFirst Posted
Study publicly available on registry
May 19, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2022
CompletedNovember 17, 2025
May 1, 2022
11 months
April 27, 2021
November 14, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Breath-hold (urge to breath)
Time from start of breath-hold to urge to breathe
3 months post-operative, ON and OFF: randomised, cross over, 5-phase design
Secondary Outcomes (5)
Breath-hold (break point)
3 months post-operative, ON and OFF: randomised, cross over, 5-phase design
Peak Expiratory Flow Rate
3 months post-operative, ON and OFF: randomised, cross over, 5-phase design
Dyspnoea-12 Questionnaire
Baseline and 3 months post-operative
Oscillometry
Baseline and 3 months post-operative ON and OFF
Maximum inspiratory pressure
Baseline and 3 months post-operative ON and OFF
Study Arms (2)
ET VIM DBS patients
Essential tremor patients scheduled for VIM DBS
DT VIM DBS patients
Dystonic tremor patients scheduled for VIM DBS
Interventions
Stereotactic deep brain stimulation of ventral intermediate nucleus of thalamus
Eligibility Criteria
Sequential cohort of patients with movement disorders (ET and DT) who are scheduled for VIM DBS at John Radcliffe Hospital. All will be contacted by a member of clinical care team for the study to be offered.
You may qualify if:
- Scheduled for VIM DBS
- Diagnosis of ET or DT
You may not qualify if:
- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Alex L Green, FRCS
University of Oxford
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 27, 2021
First Posted
May 19, 2022
Study Start
September 9, 2021
Primary Completion
July 31, 2022
Study Completion
July 31, 2022
Last Updated
November 17, 2025
Record last verified: 2022-05